Author: Ian Cooper

Dec 14, 2019 San Jose / CA / USA - NIO ES8 electric SUV displayed in front of NIO headquarters; NIO is a Chinese automobile manufacturer specializing in developing electric autonomous vehicles

NIO Stock Price Rises on July Sales News

Shares of electric carmaker Nio Inc. (NIO) exploded above $14 a share on July 2020 sales news. For July 2020, the company delivered 3,553 vehicles – up 322% year over year. NIO has now delivered 17,702 vehicles for the year – up 111% year over year. “In July, we are pleased to have achieved the […]

LAC Stock Price Up Almost 300% Since March Low; Receives $40 Million In Cash

LAC Stock Price Up Almost 300% Since March Low; Receives $40 Million In Cash

Since bottoming out at $1.92 in March 2020, shares of Lithium Americas (LAC) rocketed to a recent high of $5.78.  All because there’s a potential lithium supply shortage. According to Reuters, “A new demand surge is already looming in the form of the multiple ‘green stimulus’ packages as governments try and kick-start locked-down economies. You don’t […]

PFE Stock Price Jumps on Announcement of $1.95 Billion Payout From U.S. For COVID-19 Vaccine

PFE Stock Price Jumps on Announcement of $1.95 Billion Payout From U.S. For COVID-19 Vaccine

Pfizer (PFE) just announced the U.S. government will pay $1.95 billion for PFE to produce and deliver 100 million doses of its COVID vaccine once the U.S. declares it’s safe and effective. Under the agreement, the U.S. can acquire an additional 500 million doses from PFE. “Through Operation Warp Speed, we are assembling a portfolio of vaccines […]

FATE Stock Price Jumps on License Agreement with Baylor College for Rejection-Resistant Cellular Therapies

FATE Stock Price Jumps on License Agreement with Baylor College for Rejection-Resistant Cellular Therapies

Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]